Zheyu Li - Brighten Optix Independent Director

6747 Stock  TWD 139.00  1.00  0.71%   

Insider

Zheyu Li is Independent Director of Brighten Optix since 2019.
Tenure 5 years
Phone886 2 2880 1778
Webhttps://www.brightenoptix.com.tw

Brighten Optix Management Efficiency

The company has return on total asset (ROA) of 0.1225 % which means that it generated a profit of $0.1225 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2247 %, meaning that it generated $0.2247 on every $100 dollars invested by stockholders. Brighten Optix's management efficiency ratios could be used to measure how well Brighten Optix manages its routine affairs as well as how well it operates its assets and liabilities.
Brighten Optix has accumulated 15.15 M in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Brighten Optix has a current ratio of 4.7, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Brighten Optix until it has trouble settling it off, either with new capital or with free cash flow. So, Brighten Optix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brighten Optix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brighten to invest in growth at high rates of return. When we think about Brighten Optix's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Andrew BaoLeader Electronics
N/A
Cindy SunUniversal Vision Biotechnology
N/A
ChinTzu LinRuentex Development Co
N/A
ChingYao PengAdvanced Ceramic X
N/A
Yuchi ChanUniversal Vision Biotechnology
N/A
Shunhua XiaoWiseChip Semiconductor
N/A
ShuHsin LinUniversal Vision Biotechnology
N/A
Guo LinWiseChip Semiconductor
N/A
Tony TsengNovatek Microelectronics Corp
N/A
ChungYee PaoLeader Electronics
N/A
ChienWen KuoAdvanced Ceramic X
N/A
ChengHsiao ChouExcelsior Medical Co
N/A
Tim ChiangPacific Hospital Supply
N/A
Ying GuWiseChip Semiconductor
N/A
Gangzi CongWiseChip Semiconductor
N/A
PiJung LinUniversal Vision Biotechnology
N/A
Jun ShiWiseChip Semiconductor
N/A
AnTing ChungPacific Hospital Supply
N/A
Wenqin YeWiseChip Semiconductor
N/A
Jianyue LiWiseChip Semiconductor
N/A
Rich WesterferLeader Electronics
N/A
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. BRIGHTEN OPTIX operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange. Brighten Optix (6747) is traded on Taiwan OTC Exchange in Taiwan and employs 9 people.

Management Performance

Brighten Optix Leadership Team

Elected by the shareholders, the Brighten Optix's board of directors comprises two types of representatives: Brighten Optix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brighten. The board's role is to monitor Brighten Optix's management team and ensure that shareholders' interests are well served. Brighten Optix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brighten Optix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zheyu Li, Independent Director
Taixiong Wu, Chairman of the Board, General Manager
Guanhan Wu, General Manager of China Business-General Manager's Office, Director
Zhuyin Ye, Assistant General Manager of Finance & Accounting Center
Shifang Qiu, Independent Director
Zhiyuan You, Director
Yi Ye, Chief Operating Officer-General Manager's Office
Meijuan Dai, Independent Director
Yicong Wu, Head of Research & Development, Director

Brighten Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brighten Optix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Brighten Optix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brighten Optix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brighten Optix will appreciate offsetting losses from the drop in the long position's value.

Moving together with Brighten Stock

  0.833218 Universal Vision BioPairCorr
  0.684104 Excelsior MedicalPairCorr
  0.846762 Delta Asia InternationalPairCorr

Moving against Brighten Stock

  0.792891 CTBC Financial HoldingPairCorr
  0.792891B CTBC Financial HoldingPairCorr
  0.672883 China DevelopmentPairCorr
  0.594129 United OrthopedicPairCorr
  0.50050 YuantaP shares TaiwanPairCorr
The ability to find closely correlated positions to Brighten Optix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brighten Optix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brighten Optix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brighten Optix to buy it.
The correlation of Brighten Optix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brighten Optix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brighten Optix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brighten Optix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Brighten Stock Analysis

When running Brighten Optix's price analysis, check to measure Brighten Optix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brighten Optix is operating at the current time. Most of Brighten Optix's value examination focuses on studying past and present price action to predict the probability of Brighten Optix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brighten Optix's price. Additionally, you may evaluate how the addition of Brighten Optix to your portfolios can decrease your overall portfolio volatility.